STIMUFEND

NDC 65219-371 · Fresenius Kabi USA, LLC

Generic namepegflilgrastim-fpgk

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)PEGFILGRASTIM

Strength6 mg/.6mL

Pharmacologic classGranulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]

Marketing categoryBLA

Packages

65219-371-10 — 1 BLISTER PACK in 1 CARTON (65219-371-10) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE

Billed under HCPCS

Q5127 — Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg Medicare Part B payment limit (ASP + 6%): $143.67

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0069-0324 — pegfilgrastim-apgf, 55513-099 — pegfilgrastim, 55513-190 — pegfilgrastim, 61314-866 — pegfilgrastim-bmez, 69448-025 — pegfilgrastim-cbqv, 69448-026 — pegfilgrastim-cbqv, 69448-027 — pegfilgrastim-cbqv, 70114-101 — pegfilgrastim-cbqv, 70114-120 — pegfilgrastim-cbqv, 70114-130 — pegfilgrastim-cbqv, 70121-1627 — pegfilgrastim, 70748-273 — pegfilgrastim-unne, 72603-402 — pegflilgrastim-fpgk, 83257-005 — pegfilgrastim-jmdb

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.